Activated protein C resistance and the FV:R506Q mutation in a random population sample -: Associations with cardiovascular risk factors and coagulation variables

被引:0
|
作者
Lowe, GDO
Rumley, A
Woodward, M
Reid, E
Rumley, J
机构
[1] Univ Glasgow, Royal Infirm, Dept Med, Glasgow G31 2ER, Lanark, Scotland
[2] Univ Reading, Dept Appl Stat, Reading RG6 2AH, Berks, England
[3] Univ Glasgow, Yorkhill Hosp, Dept Med Genet, Glasgow, Lanark, Scotland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activated protein C (APC) resistance, defined as a low APC ratio, is associated with the factor V mutation R(506)Q (factor V Leiden). APC ratio map also be influenced by other clinical and coagulation variables, which we studied in 460 men and 495 women aged 25-74 years, from a random population sample (Glasgow MONICA Survey). APC ratio correlated positively with APTT; and inversely with factor VIIIc, factor IXc, antithrombin activity, prothrombin F1+2 fragment, and thrombin-antithrombin complexes; but not with other coagulation variables. APC ratio decreased with age, but APTT did not. APC ratio and APTT were significantly lower in women versus men? and were significantly lower in users of oral contraceptives or hormone replacement therapy. The EV:R(506)Q mutation (prevalence 2.5%) was associated with lower APC ratio and protein C and S activities and with higher factor VIIIc levels; but not with increases in F1+2 fragment or thrombin-antithrombin complexes. APC ratio correlated inversely with total cholesterol and di astolic blood pressure; and in women with triglycerides, systolic blood pressure, and body mass index. Obesity was associated with a significantly lower APC ratio. In contrast, smoking markers correlated positively with APC ratio in men. These associations of APC ratio may be relevant to the increased risks of venous thrombosis with age, female sex, oestrogen use,obesity and high factor VIIIc levels. The association of APC resistance with elevated plasma levels of coagulation markers suggests that this phenotype represents an in vivo hypercoagulable state.
引用
收藏
页码:918 / 924
页数:7
相关论文
共 50 条
  • [41] Frequency of factor V Arg506 to Gin mutation (FV Leiden) and activated protein C resistance in blood donors in Argentina. A preliminary study
    Hepner, M
    Roldan, A
    Pieroni, G
    Frontroth, J
    Serviddio, RM
    Torres, AF
    Sciuccati, G
    Bonduel, M
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS919 - PS919
  • [42] Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism
    Rodeghiero, F
    Tosetto, A
    ANNALS OF INTERNAL MEDICINE, 1999, 130 (08) : 643 - +
  • [43] Activated protein C resistance and factor V Leiden mutation are risk factors for cerebral sinus thrombosis
    Siegert, CEH
    Smelt, AHM
    deBruin, TWA
    STROKE, 1997, 28 (06) : 1291 - 1292
  • [44] The factor V R506Q and prothrombin 20210G→A mutations as independent risk factors for venous thromboembolism:: A population-based case-control study
    Heit, JA
    Silverstein, MD
    Petterson, TM
    O'Fallon, WM
    Melton, LJ
    THROMBOSIS AND HAEMOSTASIS, 1999, : 387 - 387
  • [45] CO-SEGREGATION OF THROMBOSIS WITH THE FACTOR-V Q506 MUTATION IN AN EXTENDED FAMILY WITH RESISTANCE TO ACTIVATED PROTEIN-C
    BEUFE, S
    BORG, JY
    VASSE, M
    CHARBONNIER, F
    MOREAU, V
    MONCONDUIT, M
    FREBOURG, T
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (03) : 659 - 662
  • [46] Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis
    Brenner, B
    Zivelin, A
    Lanir, N
    Greengard, JS
    Griffin, JH
    Seligsohn, U
    BLOOD, 1996, 88 (03) : 877 - 880
  • [47] Associations of very high C-reactive protein concentration with psychosocial and cardiovascular risk factors in an ageing population
    Hamer, Mark
    Chida, Yoichi
    ATHEROSCLEROSIS, 2009, 206 (02) : 599 - 603
  • [48] Different anticoagulant response to activated protein C (APC-test) and to Agkistrodon Contortix Venom (ACV-test) in a family with FV-R506Q substitution
    Gemmati, D
    Verzola, I
    Mari, R
    Serino, ML
    Moratelli, S
    Ballerini, G
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS86 - PS86
  • [49] Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss -: a possible evolutionary selection mechanism
    Lindqvist, PG
    Svensson, PJ
    Dahlbäck, B
    Marsál, K
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (01) : 69 - 73
  • [50] Low prevalence of activated protein C resistance and coagulation factor V Arg(506) to Gln mutation among Japanese patients with various forms of thrombosis, and normal individuals
    Zama, T
    Murata, M
    Ono, F
    Watanabe, K
    Watanabe, R
    Moriki, T
    Yokoyama, K
    Tokuhira, M
    Ikeda, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1996, 65 (01) : 71 - 78